BetterScholar BetterScholar
10
Role
Title
Level Year L/R
🐜 Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.
7 auth. M. Mayes, J. Lacey, J. Beebe-Dimmer, B. Gillespie, Brenda C. Cooper, T. Laing, ... D. Schottenfeld
9 2003
9
🐜
🐜 Racial differences in scleroderma among women in Michigan.
12 auth. Timothy J. Laing, B. W. Gillespie, Mary B. Toth, Maureen D. Mayes, Robert H. Gallavan, Carol J. Burns, ... Jewel R. Johanns, Brenda C. Cooper, B. J. Keroack, Mary Chester M. Wasko, James V. Lacey, David Schottenfeld
7 1997
7
🐜
🐜 The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica.
10 auth. Carol J. Burns, Timothy J. Laing, Brenda W. Gillespie, S. Heeringa, Kirsten H. Alcser, Maureen D. Mayes, ... Mary Chester M. Wasko, Brenda C. Cooper, D. Garabrant, David Schottenfeld
6 1996
6
🐜
🐜 Scleroderma and solvent exposure among women.
7 auth. D. Garabrant, J. Lacey, T. Laing, B. Gillespie, M. Mayes, Brenda C. Cooper, ... D. Schottenfeld
6 2003
6
🐜
🐜 Potential risk factors for undifferentiated connective tissue disease among women: implanted medical devices.
9 auth. T. Laing, D. Schottenfeld, J. Lacey, B. Gillespie, D. Garabrant, Brenda C. Cooper, ... S. Heeringa, K. Alcser, Maureen D. Mayes
4 2001
4
🐜
🐜 Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD).
7 auth. J. Lacey, D. Garabrant, T. Laing, B. W. Gillespie, Maureen D. Mayes, Brenda C. Cooper, ... D. Schottenfeld
4 1999
4
🐜
🐜 RACIAL DIFFERENCES IN SCLERODERMA 735
12 auth. T. Laing, B. Gillespie, M. Toth, M. Mayes, R. Gallavan, C. Burns, ... Jewel R. Joha, Brenda C. Cooper, B. J. Keroack, M. Wasko, J. Lacey, David SCHO'ITENFELD
0 2005
0
🐜
🐜 A POPULATION-BASED CASE-CONTROL STUDY OF SCLERODERMA AMONGWOMEN: ASSESSMENT OF RISK FROM EXPOSURE TO SILICONE: T 127
10 auth. D. Schottenfeld, T. Laing, B. Gillespie, C. Burns, S. Heeringa, K. Alcser, ... M. D. Makes, J. Lacey, Brenda C. Cooper, D. Garabrant
0 1996
0
🐜